Injury, infection and autoimmune triggers increase CNS expression of the chemokine CCL21. Outside the CNS, CCL21 contributes to chronic inflammatory disease and autoimmunity by three mechanisms: recruitment of lymphocytes into injured or infected tissues, organization of inflammatory infiltrates into lymphoid-like structures and promotion of homeostatic CD4+ T-cell proliferation. To test if CCL21 plays the same role in CNS inflammation, we generated transgenic mice with astrocyte-driven expression of CCL21 (GFAP-CCL21 mice). Astrocyte-produced CCL21 was bioavailable and sufficient to support homeostatic CD4+ T-cell proliferation in cervical lymph nodes even in the absence of endogenous CCL19/CCL21. However, lymphocytes and glial-activation were not detected in the brains of uninfected GFAP-CCL21 mice, although CCL21 levels in GFAP-CCL21 brains were higher than levels expressed in inflamed Toxoplasma-infected non-transgenic brains. Following Toxoplasma infection, T-cell extravasation into submeningeal, perivascular and ventricular sites of infected CNS was not CCL21-dependent, occurring even in CCL19/CCL21-deficient mice. However, migration of extravasated CD4+, but not CD8+ T cells from extra-parenchymal CNS sites into the CNS parenchyma was CCL21-dependent. CD4+ T cells preferentially accumulated at perivascular, submeningeal and ventricular spaces in infected CCL21/CCL19-deficient mice. By contrast, greater numbers of CD4+ T cells infiltrated the parenchyma of infected GFAP-CCL21 mice than in wild-type or CCL19/CCL21-deficient mice. Together these data indicate that CCL21 expression within the CNS has the potential to contribute to T cell-mediated CNS pathology via: (a) homeostatic priming of CD4+ T-lymphocytes outside the CNS and (b) by facilitating CD4+ T-cell migration into parenchymal sites following pathogenic insults to the CNS.
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Introduction
The CNS is an immune privileged site (Carson et al., 2006) . Data gathered over the last two decades has clarified that CNS immune privilege is not equivalent to CNS immune isolation. Instead, CNS immune responses are regulated in a tissue-specific manner (Carson et al., 2006; Davis and Carson, 2009 ). Thus, a high threshold for initiating antigen-specific T cell responses from within the CNS does exist; yet, large numbers of T cells readily enter the CNS in response to a wide variety of insults.
T-cell influx associated with pro-inflammatory pathogen defense functions can be neurotoxic and disruptive of CNS function, as evidenced by the destructive effects of autoreactive T cells in experimental autoimmune encephalomyelitis (EAE) (Baxter, 2007) . However, in response to chronic infection by natural pathogens, the CNS can tolerate ongoing influx of activated pro-inflammatory T cells. For example, the obligate intracellular protozoan, Toxoplasma gondii (T. gondii) cannot be cleared from the CNS of infected individuals (Lambert and Barragan, 2010; Wilson et al., 2010) . Instead, IFNc producing T cells targeting T. gondii antigens are required to drive T. gondii from the cytotoxic tachyzoite stage of their life cycle to the latent cyst forming bradyzoite stage. Animal models and T cell-deficient individuals have demonstrated that continual influx of IFNc producing T cells into the CNS is also required to prevent re-emergence of cytotoxic T. gondii tachyzoites from cysts. For example, decreased T-cell influx into the CNS due to AIDS or chemotherapy leads to reactivation of cysts and development of Toxoplasmic encephalitis characterized by cognitive and motor defects associated with necrotic brain lesions.
